In this guest post, Rachel Cohen—regional executive director of the Drugs for Neglected Diseases initiative (DNDi) North America—writes about the need for research to develop new health products for neglected tropical diseases (NTDs).
Rachel M. Cohen, MPP
Regional Executive Director, North America
Drugs for Neglected Diseases initiative
Rachel M. Cohen is the Regional Executive Director of the North America office of the Drugs for Neglected Diseases initiative (DNDi). Rachel has worked in the global health and humanitarian field for more than 20 years.
Prior to joining DNDi in 2011, she worked for Doctors Without Borders/Médecins Sans Frontières (MSF) from 1999-2010. She served as Head of Mission for MSF in South Africa and Lesotho for four years, overseeing HIV/AIDS, tuberculosis, sexual violence, and migrant health programs. Before working for MSF in the field, Rachel held several positions with MSF in New York, including U.S. Director for MSF’s Access Campaign. From 2009-2015, she also served on the Board of Directors of MSF’s Operational Center in Brussels.
Prior to working with MSF, Rachel was the Director of Foundation & Corporate Giving at Housing Works, the largest grassroots AIDS service organization in the U.S., and before that, served as Program Coordinator for the US+Cuba Medical Project, where she directed medical aid, educational, and advocacy programs.
She has published a number of articles in peer-reviewed journals, co-authored numerous reports, and been quoted extensively in the media.
Rachel earned her Master in Public Policy with a Certificate in Health and Health Policy from Princeton University’s School of Public and International Affairs.